USNA

USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.

Wall Street analysts forecast USNA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for USNA is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

USANA Health Sciences Inc revenue for the last quarter amounts to 213.67M USD, increased 6.72 % YoY.

USANA Health Sciences Inc. EPS for the last quarter amounts to -0.36 USD, decreased -164.29 % YoY.

USANA Health Sciences Inc (USNA) has 1700 emplpoyees as of December 15 2025.

Today USNA has the market capitalization of 373.48M USD.